What proportion of vancomycin trough levels are drawn too early? Frequency and impact on clinical actions

American Journal of Clinical Pathology

Volumn 137, Issue 3, 2012, Pages 472-478

  Morrison, Aileen P ^a   Melanson, Stacy E F ^a   Carty, Marcy G ^a   Bates, David W ^a   Szumita, Paul M ^a   Tanasijevic, Milenko J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Patient safety; Quality; Specimen collection; Therapeutic drug monitoring; Vancomycin

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; HUMAN; PATIENT SAFETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLE; BLOOD; DRUG MONITORING; FEMALE; MALE; MIDDLE AGED; TEACHING HOSPITAL; TIME;

ANTI-BACTERIAL AGENTS; DRUG MONITORING; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; VANCOMYCIN;

EID: 84859246565     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPDSYS0DVLKFOH     Document Type: Article

References (19)

1. Moellering RC Jr. Vancomycin: a 50-year reassessment. Clin Infect Dis. 2006;42(suppl 1):S3-S4.
2. Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006;42(suppl 1):S35-S39. (Pubitemid 41832063)
3. Griffith RS. Introduction to vancomycin. Rev Infect Dis. November-December 1981;3 suppl:S200-S204.
4. Saunders NJ. Why monitor peak vancomycin concentrations? Lancet. 1994;344:1748-1750.
5. Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;42(suppl 1):S5-S12. (Pubitemid 41832060)
6. Rybak MJ, Lomaestro BM, Rotschafer JC, et al.Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009;29:1275-1279.
7. Mason GD, Winter ME. Appropriateness of sampling times for therapeutic drug monitoring. Am J Hosp Pharm. 1984;41:1796-1801. (Pubitemid 14060290)
8. Schoenenberger RA, Tanasijevic MJ, Jha A, et al.Appropriateness of antiepileptic drug level monitoring. JAMA. 1995;274:1622-1626.
9. Bernard DW, Bowman RL, Grimm FA, et al.Nighttime dosing assures postdistribution sampling for therapeutic drug monitoring of digoxin. Clin Chem. 1996;42:45-49. (Pubitemid 26030380)
10. Jones H, Lindsay, Ballard T. Improving outcomes in therapeutic drug monitoring: a case history. Clin Lab Manage Rev. 1996;10:160-166. (Pubitemid 26110777)
11. Bates DW, Soldin SJ, Rainey PM, et al.Strategies for physician education in therapeutic drug monitoring. Clin Chem. 1998;44:401-407. (Pubitemid 28087747)
12. Bates DW. Improving the use of therapeutic drug monitoring. Ther Drug Monit. 1998;20:550-555. (Pubitemid 28463448)
13. Canas F, Tanasijevic MJ, Ma'luf N, et al.Evaluating the appropriateness of digoxin level monitoring. Arch Intern Med. 1999;159:363-368. (Pubitemid 29091624)
14. Chen P, Tanasijevic MJ, Schoenenberger RA, et al.A computer-based intervention for improving the appropriateness of antiepileptic drug level monitoring. Am J Clin Pathol. 2003;119:432-438. (Pubitemid 37047867)
15. Crowley RK, Fitzpatrick F, Solanki D, et al.Vancomycin administration: the impact of multidisciplinary interventions. J Clin Pathol. 2007;60:1155-1159. (Pubitemid 47612651)
16. Traugott KA, Maxwell PR, Green K, et al.Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders. Am J Health Syst Pharm. 2011;68:347-352.
17. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
18. Morrison AP, Tanasijevic MJ, Goonan EM, et al.Reduction in specimen labeling errors after implementation of a positive patient identification system in phlebotomy. Am J Clin Pathol. 2010;133:870-877.
19. Poon EG, Keohane CA, Yoon CS, et al.Effect of bar-code technology on the safety of medication administration. N Engl J Med. 2010;362:1698-1707.